Home / Precision Oncology & Genomic Cancer Care
Precision Oncology & Genomic Cancer Care
Precision oncology uses the genetic profile of a tumour to choose the treatment most likely to work for that patient. Genomic testing can reveal mutations that are targetable with modern drugs.
What it includes
- Next-generation sequencing (NGS) of tumour tissue or blood (liquid biopsy)
- Targeted therapy matched to actionable mutations
- Immunotherapy guided by biomarkers (PD-L1, MSI, TMB)
- CAR-T cell therapy for selected blood cancers
Who benefits
Patients with advanced, rare or treatment-resistant cancers often benefit most.